Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Exercise activates the endocannabinoid system.

Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A.

Neuroreport. 2003 Dec 2;14(17):2209-11.

PMID:
14625449
2.

Endocannabinoids and exercise.

Dietrich A, McDaniel WF.

Br J Sports Med. 2004 Oct;38(5):536-41. Review.

3.

Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism.

Awumey EM, Howlett AC, Diz DI.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H520-1. Review. No abstract available.

4.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678
5.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

PMID:
15550444
6.

Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.

Gertsch J.

Planta Med. 2008 May;74(6):638-50. doi: 10.1055/s-2008-1034302. Epub 2008 Feb 14. Review.

PMID:
18275004
7.

Anandamide and vanilloid TRPV1 receptors.

Ross RA.

Br J Pharmacol. 2003 Nov;140(5):790-801. Epub 2003 Sep 29. Review.

8.

The endocannabinoid system in neurodegeneration.

Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M.

Ital J Biochem. 2006 Sep-Dec;55(3-4):283-9. Review.

PMID:
17274532
9.

Endogenous cannabinoids: structure and metabolism.

Bisogno T.

J Neuroendocrinol. 2008 May;20 Suppl 1:1-9. doi: 10.1111/j.1365-2826.2008.01676.x. Review.

PMID:
18426492
10.

Endocannabinoid metabolic pathways and enzymes.

Ligresti A, Cascio MG, Di Marzo V.

Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):615-23. Review.

PMID:
16375679
11.

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Lambert DM, Fowler CJ.

J Med Chem. 2005 Aug 11;48(16):5059-87. Review. No abstract available.

PMID:
16078824
12.

The endocannabinoid system as a target for therapeutic drugs.

Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F.

Trends Pharmacol Sci. 2000 Jun;21(6):218-24. Review.

PMID:
10838609
13.

Modulators of endocannabinoid enzymic hydrolysis and membrane transport.

Ho WS, Hillard CJ.

Handb Exp Pharmacol. 2005;(168):187-207. Review.

PMID:
16596775
14.

Discovery and isolation of anandamide and other endocannabinoids.

Hanus LO.

Chem Biodivers. 2007 Aug;4(8):1828-41. Review. No abstract available.

PMID:
17712821
15.

The quest for a vascular endothelial cannabinoid receptor.

Kunos G, Bátkai S, Offertáler L, Mo F, Liu J, Karcher J, Harvey-White J.

Chem Phys Lipids. 2002 Dec 31;121(1-2):45-56. Review.

PMID:
12505689
16.

Endogenous cannabinoids: metabolism and their role in reproduction.

Habayeb OM, Bell SC, Konje JC.

Life Sci. 2002 Mar 15;70(17):1963-77. Review.

PMID:
12148689
17.

Anandamide: an update.

Smita K, Sushil Kumar V, Premendran JS.

Fundam Clin Pharmacol. 2007 Feb;21(1):1-8. Review.

PMID:
17227440
18.

Endocannabinoids and the gut.

Pinto L, Capasso R, Di Carlo G, Izzo AA.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):333-41. Review. Erratum in: Prostaglandins Leukot Essent Fatty Acids. 2002 Oct;67(4):275.

PMID:
12052047
19.

The endogenous cannabinoid system and the treatment of marijuana dependence.

Piomelli D.

Neuropharmacology. 2004;47 Suppl 1:359-67. Review.

PMID:
15464150
20.

The endocannabinoid signaling system: pharmacological and therapeutic aspects.

Fowler CJ, Holt S, Nilsson O, Jonsson KO, Tiger G, Jacobsson SO.

Pharmacol Biochem Behav. 2005 Jun;81(2):248-62. Review.

PMID:
15935456

Supplemental Content

Support Center